Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-19 4:50 pm Purchase | 2025-02-11 | 13G | Sun Country Airlines Holdings, Inc. SNCY | Citadel Advisors LLC | 3,196,914 6.100% | 3,196,914 (New Position) | Filing History |
| 2025-02-14 6:32 pm Sale | 2024-12-31 | 13G | COMPASS Pathways plc CMPS | Citadel Advisors LLC | 1,166,576 1.700% | -4,268,100 (-78.53%) | Filing History |
| 2025-02-14 6:25 pm Purchase | 2024-12-31 | 13G | Terns Pharmaceuticals, Inc. TERN | Citadel Advisors LLC | 3,465,307 4.100% | 54,543 (+1.60%) | Filing History |
| 2025-02-14 6:24 pm Purchase | 2024-12-31 | 13G | Protara Therapeutics, Inc. TARA | Citadel Advisors LLC | 1,627,734 4.700% | 414,602 (+34.18%) | Filing History |
| 2025-02-14 6:22 pm Sale | 2024-12-31 | 13G | Lyra Therapeutics, Inc. LYRA | Citadel Advisors LLC | 21,083 0.000% | -4,265,844 (-99.51%) | Filing History |
| 2025-02-14 6:20 pm Sale | 2024-12-31 | 13G | Korro Bio, Inc. KRRO | Citadel Advisors LLC | 369,733 3.900% | -159,518 (-30.14%) | Filing History |
| 2025-02-14 6:18 pm Sale | 2024-12-31 | 13G | Hawaiian Electric Industries, Inc. HE | Citadel Advisors LLC | 643,461 0.400% | -8,206,776 (-92.73%) | Filing History |
| 2025-02-14 6:13 pm Sale | 2024-12-31 | 13G | Acelyrin, Inc. SLRN | Citadel Advisors LLC | 4,218,748 4.200% | -2,430,694 (-36.55%) | Filing History |
| 2025-02-14 5:24 pm Unchanged | 2025-01-23 | 13G | Arvinas, Inc. ARVN | Citadel Advisors LLC | 3,480,125 5.100% | 0 (Unchanged) | Filing History |
| 2025-01-30 4:09 pm Purchase | 2025-01-23 | 13G | Arvinas, Inc. ARVN | Citadel Advisors LLC | 3,480,125 5.100% | 3,480,125 (New Position) | Filing History |
| 2024-12-13 5:02 pm Purchase | 2024-12-06 | 13G | Nkarta, Inc. NKTX | Citadel Advisors LLC | 3,819,867 5.400% | 3,819,867 (New Position) | Filing History |
| 2024-11-14 4:24 pm Sale | 2024-09-30 | 13G | Enliven Therapeutics, Inc. ELVN | Citadel Advisors LLC | 1,734,094 3.700% | -660,354 (-27.58%) | Filing History |
| 2024-11-14 4:23 pm Sale | 2024-09-30 | 13G | Dyne Therapeutics, Inc. DYN | Citadel Advisors LLC | 2,960,081 3.000% | -112,506 (-3.66%) | Filing History |
| 2024-11-14 4:21 pm Sale | 2024-09-30 | 13G | Dutch Bros Inc. BROS | Citadel Advisors LLC | 2,974,719 2.600% | -1,099,167 (-26.98%) | Filing History |
| 2024-11-14 4:20 pm Purchase | 2024-09-30 | 13G | COMPASS Pathways plc CMPS | Citadel Advisors LLC | 5,434,676 8.000% | 2,239,159 (+70.07%) | Filing History |
| 2024-11-14 4:20 pm Sale | 2024-09-30 | 13G | Zentalis Pharmaceuticals, Inc. ZNTL | Citadel Advisors LLC | 2,737,221 3.900% | -1,001,261 (-26.78%) | Filing History |
| 2024-11-14 4:19 pm Sale | 2024-09-30 | 13G | VistaGen Therapeutics, Inc. VTGN | Citadel Advisors LLC | 1,158,219 4.200% | -442,549 (-27.65%) | Filing History |
| 2024-11-14 4:19 pm Sale | 2024-09-30 | 13G | Vigil Neuroscience, Inc. VIGL | Citadel Advisors LLC | 1,442,489 3.600% | -719,413 (-33.28%) | Filing History |
| 2024-11-14 4:19 pm Sale | 2024-09-30 | 13G | Bolt Biotherapeutics, Inc. BOLT | Citadel Advisors LLC | 0 0.000% | -2,458,958 (Position Closed) | Filing History |
| 2024-11-14 4:18 pm Sale | 2024-09-30 | 13G | UWM Holdings Corporation UWMC | Citadel Advisors LLC | 8,995,096 7.900% | -17,254 (-0.19%) | Filing History |